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Abstract Therapeutic effect of recombinant tissue-plas-
minogen activator (rt-PA) is time dependent. There is
limited evidence whether localization of stroke within the
posterior circulation (PCS) is associated with a treatment
delay. We aimed to analyze within a nationwide multi-
center cohort whether duration of pre- and intra-hospital
patient management differs between patients with PCS and
anterior circulation strokes (ACS). We studied onset-to-
door-times (ODT) and door-to-needle-times (DNT) of all
patients with acute ischemic stroke (IS) enrolled in the
Austrian Stroke Unit Registry according to infarct local-
ization. Classification into PCS and ACS was based on
clinical presentation applying the criteria used in the
Oxfordshire Community Stroke Project. Relationships
between ODT, respectively, DNT and explanatory vari-
ables were modeled by multivariate linear regression.
Between 2003 and 2015, 71010 patients with IS were
enrolled, 11,924 with PCS and 59,086 with ACS. Overall,
the ODT was significantly longer in PCS: median (IQR):
170 (25th, 75th%: 79,420) min versus 110 (60,240);
p\ 0.001; this finding held true in multivariable analysis.
In 10535 rt-PA-treated patients (1022 PCS/9832 ACS),
ODT and DNT were significantly longer among those with
PCS: ODT: median: 80 min (55,120) versus 72 (50,110),
p\ 0.001; DNT: 57 (35.90) versus 45 (30.67), p\ 0.001.
In the multivariate model, PCS was significantly associated
with delay in the DNT. In conclusion, in this large
nationwide cohort, patient management was significantly
Electronic supplementary material The online version of this
article (doi:10.1007/s00415-016-8330-x) contains supplementary





















1 Department of Neurology, Krankenanstalt Rudolfstiftung,
Vienna, Austria
2 Danube University Krems and Gesundheit O¨sterreich GmbH/
BIQG, Vienna, Austria
3 Department of Neurology, Krankenhaus Barmherzige
Bru¨der, Vienna, Austria
4 Department of Neurology, Medical University of Vienna,
Waehringer Guertel 18-20, 1090 Vienna, Austria
5 Department of Neurology, Medical University of Innsbruck,
Innsbruck, Austria
123
J Neurol (2017) 264:131–138
DOI 10.1007/s00415-016-8330-x
slower in PCS as compared to ACS. Increasing awareness
about these delays and further elaboration of the underlying
causes may translate into higher proportions of patients
with PCS receiving rt-PA.
Keywords All cerebrovascular disease/stroke  Infarction 
Cohort studies  Intravenous thrombolysis  Posterior
circulation stroke
Introduction
Approximately one-fifth of ischemic strokes occur in the
posterior circulation [1]. However, compared to anterior
circulation strokes (ACS) percentage of patients with
posterior circulation strokes (PCS) receiving intravenous
recombinant tissue-plasminogen activator (rt-PA) was
lower across different stroke registries even though
approval does not exclude specific localizations such as
posterior circulation [2–5]. This difference might be
influenced by underrepresentation of PCS in randomized
controlled trials [6–10]. In addition, clinical symptoms of
PCS differ markedly from ACS and may be misinterpreted
in clinical practice [1, 11]. This may account for delays in
the prehospital setting but also after arrival in hospital.
While only few smaller studies reported time intervals
before thrombolysis (i.e., onset-to-treatment-times, OTT)
stratified by ACS and PCS [3, 5, 12] only one evaluated
onset-to-door-(ODT) and door-to-needle (DNT)-times
specifically [12]. As the therapeutic effect of rt-PA treat-
ment in stroke is highly time dependent, detailed knowl-
edge of pre- and intra-hospital time intervals and factors
associated with delays is crucial to adapt treatment algo-
rithms [13–15]. Uncertainties in relation with transient
symptoms related to the posterior circulation can result in
lower rates of diagnosis of TIAs [16]. Therefore, both pre-
and intra-hospital delays might arise. Misdiagnosis and
delays may have significant implications for treatment and
could have potential medicolegal consequences.
We, therefore, aimed to analyze in a large nationwide
cohort of patients with acute ischemic stroke (Austrian
Stroke Unit Registry, ASUR) whether pre- and intra-hos-




The methodology of the ASUR including definitions of
clinical variables has been described previously [17, 18].
Briefly, the ASUR is a network including all Austrian
stroke units collecting data on standard characteristics and
acute management of all patients with stroke admitted to
one of currently 36 centers since 2003. Data acquisition
and rating of clinical scales are performed by experienced
stroke neurologists. Clinical evaluations are conducted at
the time of admission to and at discharge from the stroke
units. The resulting web-based database includes online
plausibility checks. Symptomatic intracerebral hemorrhage
(SICH) was rated according to National Institute of Neu-
rological Disorders and Stroke criteria (any computer
tomography (CT) or magnetic resonance imaging (MRI)
documented bleeding with clinical deterioration of at least
one point on the National Institute of Health Stroke Scale
(NIHSS) or leading to death within 7 days) [6]. The initial
stroke syndrome was categorized according to the
Oxfordshire Community Stroke Project (OCSP) [19].
The ASUR is part of a governmental quality assessment
program for stroke care in Austria financed by the Federal
Ministry of Health. It is based on the federal law promoting
quality in health (Gesundheitsqualita¨tsgesetz). All data are
anonymized and centrally administered by the Gesundheit
O¨sterreich GmbH—the national research and planning
institute for health care and a competence and funding
center of health promotion. All scientific analyses are
approved and supervised by an academic review board
[17, 18, 20].
Statistical methods
We studied ODT and DNT of enrolled patients with ACS
and PCS. Kruskal–Wallis one-way analysis of variance
was performed for univariate analysis of time intervals
stratified by infarct localization. Associations of ODT and
DNT with other clinical variables were analyzed by mul-
tivariate linear regression models. The model specification
was done using bidirectional stepwise variable selection
procedure, optimizing the Bayesian Information Criterion.
Following potentially explanatory variables were included
into the selection procedure for the ODT model: infarct
localization (ACS or PCS), type of transport (ambulance
crew with or without emergency physician, private trans-
port, secondary transport), date of admission, stroke
severity at presentation (measured by the NIHSS), age, pre-
stroke modified Rankin Scale (mRS), sex, prior hyperten-
sion, prior diabetes mellitus, previous history of stroke,
previous history of myocardial infarction (MI), hyperlipi-
demia, prior atrial fibrillation, other cardiac illness, prior
peripheral artery disease, current smoker, history of alcohol
abuse, time of presentation (admission during working
hours or non-working hours). The variable selection pro-
cedure for the DNT model included the same variables as
described for the ODT model but imaging modality (CT or
MRI) and treating stroke center served as additional
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explanatory variables. Grouping of stroke centers was done
according to rates of rt-PA treatment: thrombolysis rate
\10%, 10–20%,[20%. We considered potential two-way
interactions between all explanatory variables and relied on
bottom-up model selection for determining significant
interactions and explanatory variables. Due to the skewed
distribution, the log-transformed ODT and DNT were used
as target variables. The potential confounders age, stroke
severity (measured by the NIHSS) and year of admission
were coded using a higher degree polynomial to allow for
continuous but non-linear, non-monotonous relationships.
The appropriate degrees of the polynomials were deter-
mined with analyses of variance (ANOVA). To estimate
the number of patients lost for rt-PA treatment due to PCS-
related delay, we multiplied the number of PCS with the
difference of the rates of rt-PA treatment: NPCS 9
(RACS - RPCS) where N is the number of patients and R is
the rt-PA-rate. rt-PA rates changed over the study period
and we used data of the last two years only for this com-
putation. All data were processed using the statistical
environment R, version 2.15.2.
Ethics approval
The study was approved by the Ethics Committee of the




Between March 2003 and February 2015, 71010 adult
patients with IS were recorded in the ASUR, 11924 with PCS
and 59086 with ACS. Patients with PCS had a significantly
longer ODT compared to ACS: median: 170 min (25th per-
centile: 79 min, 75th percentile: 420 min) versus 110 (60,
240); p\0.001 (Table 1). Demographics of all enrolled
patients are shown in Table 1. In the multivariate analysis,
patients with PCS lost on average 27 min compared to ACS
before arrival to hospital (95% CI 23–31, p\0.001; Sup-
plementary Table I). Other variables significantly associated
with a delayed ODT were stroke severity, type of transport,
age, diabetes, atrial fibrillation and year of admission. Only
53.8% of patients with PCS arrived at hospital within
180 min as compared to 68.4% in patients with ACS (Fig. 1).
The delays of ODT in patients with PCS were detectable over
the entire study period (Supplementary Table I). Based on the
proportion of rt-PA treatment in ACS between 2010 and
2014, we calculated that on average 100 patients with PCS
per year potentially eligible for rt-PA treatment are lost due to
prehospital delays (Supplementary Table III).
Patients treated with rt-PA
10854 (15.2%) patients with IS were treated with rt-PA
(1022 with PCS and 9832 with ACS). Percentage of
patients treated with rt-PA was lower in PCS as compared
to ACS (8.6 versus 16.6%). Among rt-PA-treated patients,
those with PCS were younger, more often male, had a
lower NIHSS at baseline and atrial fibrillation was less
often present (Table 2).
Without adjustment for confounding, OTT, ODT and
DNT all were significantly longer among rt-PA-treated
patients with PCS as compared to patients with ACS: OTT:
median: 145 min (25th percentile: 108 min, 75th per-
centile: 195 min) versus 120 (95, 165), p\ 0.001; ODT:
median 80 (55, 120) versus 72 (50, 110), p\ 0.001; DNT:
median 57 (35, 90) versus 45 (30, 67), p\ 0.001 (Table 2).
PCS was significantly associated with a delay in the
DNT after adjustment for confounding factors. The DNT
was on average 13 min longer in patients with PCS (95%
CI 10–17, p\ 0.001, Supplemental Table II-R). Other
variables significantly associated with a prolonged DNT
were stroke severity, treating stroke center, type of imag-
ing, type of transport and year of admission. In addition, we
detected a significant interaction of the NIHSS and PCS
(Supplemental Table II-R). In an adjusted analysis of
associations of DNT, stroke severity and localization, we
detected a positive correlation between stroke severity and
treatment delay except for patients with mild stroke
(Fig. 2). The delays of DNT in patients with PCS were
detectable over the entire study period (Suppl. Table II-R).
In multivariable analysis of patients treated with rt-PA,
the association between ODT and PCS lost significance
(data not shown).
Discussion
In this analysis of nationwide data of the ASUR, we
detected delays in pre- and intra-hospital time intervals in
patients with acute ischemic stroke within the posterior
circulation. As symptoms of PCS can mimic other disor-
ders, they can be misinterpreted easily not only by non-
neurologists but also by neurologists [11].
ODT
Screening tools such as the Face Arm Speech Test (FAST)
developed for prehospital identification of stroke patients
are less sensitive for identification of PCS compared to
ACS [21]. This lack of early identification of symptoms
might account for delays in prehospital management
leading ultimately to ineligibility for thrombolytic treat-
ment. However, there is limited evidence from the
J Neurol (2017) 264:131–138 133
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literature whether stroke localization is related to delay in
preclinical time intervals so far: two prior studies both from
the pre-rt-PA era [22, 23] did not detect significant dif-
ferences and only one of them stratified stroke type
according to the OCSP classification [23]. In our study, we
detected in all patients, irrespective of rt-PA treatment,
substantially longer durations of prehospital patient man-
agement in patients with PCS as compared to patients with
ACS. On average, patients with PCS lost 27 min. Rele-
vantly, only half of patients with PCS arrived within 3 h in
hospital compared to 2/3 in ACS. Based on these data, we
estimated that on average 100 patients with PCS per year
potentially eligible for rt-PA treatment might have been
missed due to prehospital delays. As a consequence, faster
prehospital management could result in an almost twofold
increase of the thrombolysis rate in patients with PCS.
In addition, prehospital loss of patients potentially eli-
gible for rt-PA treatment might also explain the observed
lack of association of infarct localization (i.e., ACS versus
PCS) and the ODT in the selected group of patients treated
with rt-PA, which is in agreement with previous work [12].
The delay of patients with PCS reflects that diagnostic
tools used in the prehospital setting do not focus on PCS-
related symptoms. Therefore, both education and
Table 1 Baseline
characteristics of all patients
stratified by infarct localization
ACS (n = 59086) PCS (n = 11924)
Age, years median (25th, 75th%) 74.4 (64.6, 82.4) 70.6 (59.8, 79.1)
Male, sex (%) 30249 (51.2) 7119 (59.7)
NIHSS at baseline, median (25th, 75th%) 4 (2, 10) 3 (1, 5)
Prior functional status mRS = 0, n (%) 39679 (67.2) 8814 (73.9)
Vascular risk factors, n (%)
Hypertension 47494 (80.4) 9316 (78.1)
Diabetes mellitus 14944 (25.3) 2982 (25)
Hyperlipidemia 31898 (54) 6668 (55.9)
Atrial fibrillation 16543 (28) 2590 (21.7)
Smoking 1684 (17.1) 176 (17.2)
History of stroke 14137 (23.9) 2545 (21.3)
Previous myocardial infarction 5679 (9.6) 997 (8.4)
Previous peripheral artery disease 4091 (7) 808 (6.8)
Regular drinking 4638 (7.8) 914 (7.7)
Etiology
Cardio-embolism, n (%) 15914 (26.9) 2551 (21.4)
Large artery disease, n (%) 7628 (12.9) 1295 (10.9)
Small artery disease, n (%) 15340 (26) 2746 (23)
Other, n (%) 1187 (2) 419 (3.5)
Undetermined, n (%) 19017 (32.2) 4913 (41.2)
Type of transport
Ambulance without emergency physician 28067 (48.6) 5073 (42.8)
Ambulance with emergency physician 14350 (24.4) 2302 (19.4)
Private transport 8885 (15.1) 2517 (21.2)
Secondary transporta 7010 (11.9) 1966 (16.6)
Image modality
Computer tomography 49098 (83.9) 8911 (75.3)
Magnet resonance imaging 5978 (10.2) 1782 (15.1)
Time of admission
Working hoursb 27932 (47.3) 5772 (48.4)
Non-working hoursc 31152 (52.7) 6152 (51.6)
NIHSS National Institutes of Health Stroke Scale, mRS modified Rankin Scale, ACS anterior circulation
stroke, PCS posterior circulation stroke
a Transport via another hospital to a stroke unit
b Monday–Friday 8–16 h
c Monday–Friday 16–8 h and weekend
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optimized screening tools need to take typical symptoms of
PCS into account. For instance, adding elements used by
the three-step bedside examination for differential diag-
nosis of acute vestibular syndrome may increase detection
rates of PCS [24]. Moreover, addition of ataxia testing as
well as visual field testing may substantially increase
specificity and sensitivity of the FAST-test [21]. Further-
more, most symptoms preceding PCS—so-called transient
neurological attacks (TNAs)—do not satisfy traditional
definitions of TIAs [16]. Therefore, evaluation of TNAs
could be useful in screening for PCS. Randomized studies
testing prehospital screening tools that include those tests
for PCS are warranted.
DNT
In patients with PCS, the DNT was on average 13 min
longer compared to patients with ACS. This is a substantial
delay, given that even small reductions in time-to-throm-
bolysis translate into a significant gain of healthy lifetime
[14]. While we did not observe any differences in DNT in
patients with mild stroke, we detected a significant delay in
DNT for patients with PCS with moderate and severe
deficits. In those with the most severe strokes, this obser-
vation might be explained by a greater necessity for
intensive care measures in patients with PCS. However, the
observed delay in DNT in PCS did not only include
patients with the most severe strokes but also those with
moderate severity. There are some possible explanations
for this finding: First, the NIHSS has limitations for
assessment of PCS and symptoms not measured by the
NIHSS might contribute to time delays [3, 5, 12]. This is
reflected by our observation of overall lower NIHSS scores
in patients with PCS, which is in agreement with previous
work [3, 5, 12, 25, 26]. It is, therefore, possible that clinical
deficits have been underestimated by the NIHSS [25, 26].
Second, incorrect patient triage might have contributed to
the delay in DNT. Even if in the ASUR, the majority of
patients subsequently receiving treatment with rt-PA
arrived via ambulance making triage errors in the ER less
likely, we cannot exclude that triage errors or errors in
hospital pre-notification may have contributed to delays in
DNT [28]. Third, in PCS, MRI has been more often per-
formed which might have contributed to the observed
delay; however, the prolonged DNT was irrespective of
type of imaging in the multivariate analysis.
Time to treatment has been associated with clinical
outcome after ischemic stroke in clinical studies and large
clinical registers [15, 29, 30]. Reductions in prehospital
time intervals have been associated with better functional
outcome and a shorter DNT has been associated with lower
in-hospital mortality as well as lower rates of symptomatic
intracranial hemorrhage [27, 31]. Therefore, we believe
that the pre- and intra-hospital delays we observed in
patients with PCS are clinically relevant. Our study out-
numbers previous studies analyzing time intervals stratified
by infarct localization using data of a nationwide cohort of
patients (Supplementary Table IV). In addition, previous
studies focused exclusively on rt-PA-treated patients and
did not analyze ODT in untreated patients; therefore,
estimates of patients potentially lost for rt-PA-treatment
were not possible.
In contrast to previous work suggesting greater ischemic
tolerance in posterior circulation as compared to anterior
cerebral circulation [32], more recent data from the same
group could not support this hypothesis [33]. In a post hoc
analysis of the IST-3 trial, no differences were found
between ACS and PCS; however, this subgroup analysis
was certainly underpowered [34]. Therefore, at the current
stage, there is no evidence that the time-window for
intravenous thrombolysis is different in PCS and ACS and
delays might have similar negative effects on outcome and
should be avoided irrespective of stroke localization.
The observed in pre- and intra-hospital delays of our
study may have implications for daily routine and
demonstrate the need for improvement in organization of
stroke pathways. Pre- and intra-hospital screening tool and
triage systems need to implement typical symptoms of PCS
to alert stroke code protocols in a timely manner.
Our study has limitations. First, data collected in reg-
istries do not compensate for randomized studies, as
occurrence of selection bias cannot be excluded. However,
entry of patient data into the ASUR is mandatory and the
registry is part of a governmental quality assessment pro-
gram. Hence, we assume that almost all patients
Fig. 1 Association of ODT and infarct localization (PCS versus
ACS)
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undergoing treatment with rt-PA are included into the
ASUR. Second, diagnosis of PCS was clinically deter-
mined according to the OCSP classification [19]. Impor-
tantly, the OCSP classification has an excellent sensitivity
and specificity for patients with strokes in the posterior
circulation; correct classification rates of more than 85%
have been previously reported [35]. Nevertheless, we
cannot exclude that some patients with lacunar strokes in
the brainstem might have been classified as lacunar syn-
drome according to the OCSP classification [19, 35]. Third,
we were missing data on affected vessel pathology, since
CTA or MRA are not mandatory for diagnosis in the
ASUR. Therefore, it was not possible to focus on specific
conditions, such as basilar artery occlusion. However,
basilar artery occlusion was the focus of large, multina-
tional registries [36–39] and treatment options in basilar
occlusion are currently evaluated in the ongoing BASICS
study [40]. Fourth, as only patients admitted to stroke units
were included into the ASUR, we were not able to analyze
patients misdiagnosed prior to admission. However, as in
all centers participating in the ASUR recruitment is done
exclusively by neurologists specialized in acute stroke care,
we assume that false-negative rates were low. Fifth, we
cannot exclude that some stroke patients have not been
Table 2 Baseline
characteristics of patients
treated with rt-PA stratified by
infarct localization
ACS (n = 9832) PCS (n = 1022)
Age, years median (25th, 75th%) 73.8 (64, 81.4) 70.5 (59.1, 79.1)
Male, sex (%) 5073 (51.6) 629 (61.5)
NIHSS at baseline, median (25th, 75th%) 9 (5, 16) 6 (4, 12)
Prior functional status mRS = 0, n (%) 7427 (75.5) 804 (78.7)
Vascular risk factors, n (%)
Hypertension 7790 (79.2) 786 (76.9)
Diabetes mellitus 2050 (20.9) 215 (21)
Hyperlipidemia 5092 (51.8) 537 (52.5)
Atrial fibrillation 3150 (32) 230 (22.5)
Smoking 1684 (17.1) 176 (17.2)
History of stroke 1646 (16.7) 192 (18.8)
Previous myocardial infarction 871 (8.9) 95 (9.3)
Previous peripheral artery disease 503 (5.1) 48 (4.7)
Regular drinking 719 (7.3) 68 (6.7)
Etiology
Cardio-embolism, n (%) 3451 (35.1) 265 (25.9)
Large artery disease, n (%) 1394 (14.2) 145 (14.2)
Small artery disease, n (%) 1695 (17.2) 194 (19)
Other, n (%) 163 (1.7) 32 (3.1)
Undetermined, n (%) 3129 (31.8) 386 (37.8)
Type of transport
Ambulance without emergency physician 4256 (43.3) 436 (42.7)
Ambulance with emergency physician 4027 (41) 391 (38.3)
Private transport 484 (4.9) 74 (7.2)
Secondary transporta 1060 (10.8) 121 (11.8)
Image modality
Computer tomography 8091 (82.7) 723 (70.9)
Magnet resonance imaging 1074 (11) 197 (19.3)
Time of admission
Working hoursb 4304 (43.8) 473 (46.3)
Non-working hoursc 5528 (56.2) 549 (53.7)
NIHSS National Institutes of Health Stroke Scale, mRS modified Rankin Scale, ACS anterior circulation
stroke, PCS posterior circulation stroke
a Transport via another hospital to a stroke unit
b Monday–Friday 8–16 h
c Monday–Friday 16–8 h and weekend
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admitted to stroke units but directly to general neurological
wards. This might have affected predominantly patients
with minor symptoms or those with very long ODTs.
Conclusion
In this large nationwide cohort, time until arrival to hos-
pital was longer and treatment with rt-PA was delayed in
patients with PCS as compared to patients with ACS.
Whether the observed time treatment delays have an
impact on the outcome of PCS needs to be determined in
future studies. Furthermore, prospective studies, particu-
larly in the prehospital setting, are needed to determine
factors leading to delays specifically in patients with PCS.
Scales focusing on clinical symptoms related to the pos-
terior circulation might enable more efficient patient triage
in the future.
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